Edwards Life sciences Corporation Market Share Analysis

GlobalData, October 2010, Pages: 108

Edwards Life sciences Corporation Market Share Analysis

Summary

Our new report, “Edwards Lifesciences Corporation Market Share Analysis” provides in-depth information on Edwards’s market position in the different medical equipment markets it operates in. The report provides Edwards’s market share information in two key market categories - Prosthetic Heart Valve and Cardiovascular Prosthetic Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Edwards operates in - Cardiovascular Devices.
- Edwards’s company shares (in Revenues) information for all the key countries the company has presence in - United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia.
- Edwards’s company shares (in Revenues) information for all the key market categories the company has presence in - Prosthetic Heart Valve and Cardiovascular Prosthetic Devices.
- All the key data-points are for 2009 and cover all the key regions - North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any - Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Edwards operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Edwards’s market positions.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Cardiovascular Devices
3.1.1 Cardiac Assist Devices
3.1.2 Cardiac Rhythm Management
3.1.3 Cardiovascular Monitoring and Diagnostic Devices
3.1.4 Cardiovascular Prosthetic Devices
3.1.5 Cardiovascular Surgery
3.1.6 Electrophysiology
3.1.7 External Defibrillator
3.1.8 Interventional Cardiology
3.1.9 Peripheral Vascular Devices
3.1.10 Prosthetic Heart Valve
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 Financial Performance
4.4 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Cardiac Surgery Systems Product
5.2.1 Overview
5.3 Critical Care Product
5.3.1 Overview
5.3.2 Financials
5.4 Critical Care Product
5.4.1 Overview
5.4.2 Financials
5.5 Heart Valve Therapy Product
5.5.1 Overview
5.5.2 Financials
5.5.3 Key Strategies
5.6 Vascular Product
5.6.1 Overview
5.6.2 Financials
5.7 Major Products and Services
5.7.1 Overview
6 History
7 Business Strategy
7.1 Mission Statement
8 SWOT Analysis
8.1 Overview
8.2 Edwards Lifesciences Corporation Strengths
8.2.1 Focused Research and Development
8.2.2 Broad Product Portfolio
8.2.3 Strong Global Presence
8.2.4 Robust Top Line Growth
8.2.5 Efficient Use of Resources
8.2.6 Strong Growth Prospects
8.3 Edwards Lifesciences Corporation Weaknesses
8.3.1 Litigations
8.3.2 High Dependence on Few Suppliers
8.3.3 Warning Letter
8.4 Edwards Lifesciences Corporation Opportunities
8.4.1 New Product Development
8.4.2 Expansion Plans
8.4.3 Strategic Agreements
8.4.4 Growth in Cardiovascular Device Market
8.4.5 Changing Demographics
8.5 Edwards Lifesciences Corporation Threats
8.5.1 High Competition Levels
8.5.2 Regulatory Clearances
8.5.3 Rapid Technological Change
9 Competitors
10 Competitive Landscape
10.1 Cardiovascular devices Management, Global, Company Share (%), 2009
11 Edwards Lifesciences Corporation Medical Equipment Market Share Analysis
11.1 Edwards Lifesciences Corporation, Cardiovascular Devices, Global, Market Share (2009)
11.2 Edwards Lifesciences Corporation, Asia-Pacific, Market Share (2009)
11.3 Edwards Lifesciences Corporation, Europe, Market Share (2009)
11.4 Edwards Lifesciences Corporation, Middle East and Africa, Market Share (2009)
11.5 Edwards Lifesciences Corporation, North America, Market Share (2009)
11.6 Edwards Lifesciences Corporation, South and Central America, Market Share (2009)
12 Edwards Lifesciences Corporation Medical Equipment Market Share Analysis by Category
12.1 Edwards Lifesciences Corporation, Cardiovascular Devices, Global, Category Revenue Share (2009)
12.2 Edwards Lifesciences Corporation, Asia-Pacific, Category Revenue Share (2009)
12.2.1 Edwards Lifesciences Corporation, Australia, Category Revenue Share (2009)
12.2.2 Edwards Lifesciences Corporation, China, Category Revenue Share (2009)
12.2.3 Edwards Lifesciences Corporation, India, Category Revenue Share (2009)
12.2.4 Edwards Lifesciences Corporation, Japan, Category Revenue Share (2009)
12.2.5 Edwards Lifesciences Corporation, Other Asia-Pacific, Category Revenue Share (2009)
12.3 Edwards Lifesciences Corporation, Europe, Category Revenue Share (2009)
12.3.1 Edwards Lifesciences Corporation, France, Category Revenue Share (2009)
12.3.2 Edwards Lifesciences Corporation, Germany, Category Revenue Share (2009)
12.3.3 Edwards Lifesciences Corporation, Italy, Category Revenue Share (2009)
12.3.4 Edwards Lifesciences Corporation, Spain, Category Revenue Share (2009)
12.3.5 Edwards Lifesciences Corporation, United Kingdom, Category Revenue Share (2009)
12.3.6 Edwards Lifesciences Corporation, Other Europe, Category Revenue Share (2009)
12.4 Edwards Lifesciences Corporation, Middle East and Africa, Category Revenue Share (2009)
12.5 Edwards Lifesciences Corporation, North America, Category Revenue Share (2009)
12.5.1 Edwards Lifesciences Corporation, Canada, Category Revenue Share (2009)
12.5.2 Edwards Lifesciences Corporation, United States, Category Revenue Share (2009)
12.6 Edwards Lifesciences Corporation, South and Central America, Category Revenue Share (2009)
12.6.1 Edwards Lifesciences Corporation, Brazil, Category Revenue Share (2009)
12.6.2 Edwards Lifesciences Corporation, Other South and Central America, Category Revenue Share (2009)
13 Share Holding Structure
14 Key Employees
15 Key Employee Biographies
16 Company Statement
17 Locations And Subsidiaries
17.1 Head Office
17.2 Other Locations & Subsidiaries
18 Financial Deals Landscape
18.1 Edwards Lifesciences Corporation, Deals Volume Summary, 2005 to YTD 2010
19 Edwards Lifesciences Corporation, Deals Summary By Region, 2005 to YTD 2010
20 Edwards Lifesciences Corporation Detailed Deal Summary
20.1 Asset Purchase
20.1.1 Edwards Lifesciences Acquires CardioVations Product Line From Ethicon
20.2 Venture Financing
20.2.1 Embrella Cardiovascular Secures $6.7 Million In Series B Financing
20.2.2 Vascular Architects Secures $6.6 Million In Preferred Stock Financing
20.3 Partnerships
20.3.1 Endologix Signs Distribution Agreement With Edwards Lifesciences
20.3.2 Edwards Lifesciences Enters Into An Agreement With DexCom
20.3.3 Carbomedics Enters Into Licensing Agreement With Edwards LifeSciences
20.4 Divestiture - Assets
20.4.1 Baxter International Acquires Hemofiltration Product Line From Edwards Lifesciences
20.4.2 Edwards Lifesciences Sells LifeStent Product Line Assets To C. R. Bard
20.4.3 Edwards Lifesciences Sells Perfusion Products Business To Nipro Group
20.4.4 Angiotech Acquires Lifespan Vascular Graft Product Line From Edwards Lifesciences
20.4.5 Terumo Acquires Cardiopulmonary Products Business From Edwards Lifesciences
20.5 Acquisition
20.5.1 Edwards Lifesciences Acquires Percutaneous Valve Technologies
21 Recent Developments
21.1 Strategy And Business Planning
21.1.1 Oct 08, 2009: Edwards Lifesciences To Expand Its Manufacturing And R&D Capability
21.1.2 Jun 26, 2009: Edwards Lifesciences Opens New Regional Head Quarters In Nyon, Switzerland
21.1.3 Jun 23, 2009: Baxter To Acquire Hemofiltration Product Line From Edwards Lifesciences
21.1.4 May 22, 2008: Edwards Lifesciences Opens New Singapore Heart Valve Facility
21.2 Financial Announcements
21.2.1 Jul 21, 2010: Edwards Lifesciences Reports Net Income Of $57.5 Million In Q2 2010
21.2.2 Apr 20, 2010: Edwards Lifesciences Reports Net Income Of $47.7 Million In Q1 2010
21.2.3 Feb 04, 2010: Edwards Lifesciences Reports Net Income Of $229.1 Million In 2009
21.2.4 Oct 22, 2009: Edwards Lifesciences Reports Net Income Of $73.5 Million In Q3 2009
21.2.5 Jul 20, 2009: Edwards Lifesciences Posts Net Income Of $47.5 Million In Q2 2009
21.2.6 Apr 27, 2009: Edwards Lifesciences Posts Net Income Of $60.5 Million For Q1 2009
21.2.7 Feb 03, 2009: Edwards Lifesciences Reports 2008 Results
21.2.8 Dec 11, 2008: Edwards Lifesciences Provides Financial Guidance For The Year 2009
21.2.9 Oct 21, 2008: Edwards Lifesciences Reports 3Q 2008 Results
21.2.10 Oct 14, 2008: Edwards Lifesciences To Report 3Q 2008 Results
21.2.11 Jul 22, 2008: Edwards Lifesciences Reports 2Q 2008 Results
21.2.12 Apr 22, 2008: Edwards Lifesciences Provides Financial Guidance For 2008
21.2.13 Apr 22, 2008: Edwards Lifesciences Reports Q1 2008 Results
21.2.14 Feb 05, 2008: Edwards Lifesciences Reports Q4 2007 Results
21.2.15 Oct 22, 2007: Edwards Lifesciences Declares Q3 2007 Results
21.2.16 Jul 23, 2007: Edwards Lifesciences Reports Q2 2007 Results
21.2.17 Apr 23, 2007: Edwards Lifesciences Reports Q1 2007 Results
21.2.18 Feb 05, 2007: Edwards Lifesciences Reports Q4 2006 Results
21.2.19 Oct 19, 2006: Edwards Lifesciences Reports Q3 2006 Results
21.2.20 Jul 24, 2006: Edwards Lifesciences Reports Q2 2006 Results
21.2.21 May 11, 2006: Edwards Lifesciences Announces Approval of New Stock Repurchase
21.2.22 Apr 20, 2006: Edwards Lifesciences Reports Q1 2006 Results
21.2.23 Feb 02, 2006: Edwards Lifesciences Reports Q4 2005 Results
21.3 Corporate Communications
21.3.1 Feb 12, 2010: Edwards Lifesciences Elects Wesley W. Von Schack To Its Board
21.3.2 May 07, 2009: Edwards Lifesciences Elects Dr.William J. Link To Its Board
21.3.3 Apr 16, 2008: Edwards Lifesciences Director Retires
21.3.4 Feb 18, 2008: Edwards Lifesciences Announces Organizational Changes
21.3.5 Mar 23, 2007: Edwards Lifesciences Appoints New Corporate Officers
21.3.6 Feb 16, 2006: Edwards Lifesciences Elects New Member To The Board
21.4 Legal and Regulatory
21.4.1 Jun 30, 2010: CoreValve Wins Patent Suit Against Edwards Lifesciences In UK
21.4.2 Apr 29, 2010: Edwards Lifesciences Prevails In German Transcatheter Heart Valve Case
21.4.3 Apr 01, 2010: Medtronic To Appeal Jury Verdict In US Patent Case Involving CoreValve Transcatheter Aortic Valve System
21.4.4 Mar 24, 2010: CoreValve Wins Another Round In Patent War With Edwards Lifesciences
21.4.5 Feb 11, 2010: Edwards Lifesciences Claims German Appellate Court Affirms Transcatheter Valve Patent Not Infringe By CoreValve
21.4.6 Jan 19, 2010: Edwards Lifesciences' Transcatheter Valve Patent Found Valid In German Court
21.4.7 Sep 23, 2009: Federal Court Finds Edwards Lifesciences' Patents For Endovascular Graft Not Infringed
21.4.8 Jun 12, 2009: Edwards Lifesciences Prevails On Validity And Infringement In UK Patent Case Against Cook
21.4.9 Mar 19, 2009: Edwards Lifesciences Prevails In German Patent Infringement Case Initiated By Cook
21.4.10 Jan 09, 2009: CoreValve Prevails In UK Patent Infringement Action With Edwards Lifesciences
21.4.11 Jan 09, 2009: Edwards Lifesciences' Transcatheter Valve Patent Found Valid In UK Court
21.4.12 Oct 16, 2008: CoreValve Wins Lawsuit Against Edwards Lifesciences In Germany
21.4.13 Mar 21, 2008: Cook Wins Patent Infringement Suit With Edwards
21.4.14 Feb 12, 2008: Edwards Lifesciences Files Lawsuit Against CoreValve
21.4.15 May 10, 2007: Edwards Lifesciences Initiates Litigation Against CoreValve
21.4.16 Jan 23, 2006: Edwards Lifesciences and Medtronic Settles Infringement Lawsuit
21.5 Government and Public Interest
21.5.1 Jul 02, 2010: Medtronic, Edwards Lifesciences And Other Device Firms Seek US Approval For Their Transcatheter Heart Valves
21.5.2 Apr 06, 2010: Edwards Lifesciences Comments On FDA Warning Letter
21.5.3 Nov 12, 2009: Medical Device Industry Accepts US Health Reform Tax: Edwards Lifesciences CEO Says
21.5.4 Sep 30, 2009: Medtronic, Edwards Go Head To Develop Catheter-Based Heart Valve Replacements
21.5.5 Sep 23, 2009: Federal Court Finds Edwards Lifesciences' Patents Not Infringed
21.5.6 Aug 05, 2009: Medtronic, Edwards Lifesciences Expect To Bring Their Heart Valves In US
21.5.7 Feb 25, 2009: Medical-Device Companies Supportive Of Comparative-Effectiveness Research
21.6 Product News
21.6.1 Sep 23, 2010: Edwards Receives Conditional FDA Approval To Begin PARTNER II Trial For Edwards SAPIEN XT Transcatheter Heart Valve
21.6.2 Sep 22, 2010: Edwards Lifesciences Announces Publication Of Results From Cohort B Of PARTNER Trial For SAPIEN Transcatheter Heart Valve
21.6.3 Sep 13, 2010: Edwards Lifesciences Launches Magna Mitral Ease Valve
21.6.4 May 25, 2010: Edwards SAPIEN Transcatheter Heart Valve Shows Positive One-Year Outcomes In Post-Market Study
21.6.5 Apr 26, 2010: Edwards Announces Enrollment Of Patients For First Clinical Study Of Edwards SAPIEN XT Valve In Japan
21.6.6 Feb 15, 2010: Edwards Unveils The Positive Clinical Outcomes Of FloTrac System
21.6.7 Jan 28, 2010: Edwards Announces Class I Recall Of Aquarius Hemodialysis System
21.6.8 Jan 25, 2010: Edwards Announces Initiation Of TRITON Study For Project Odyssey
21.6.9 Nov 10, 2009: FDA Announces Class I Recall Of Edwards CardioVations EndoClamp Aortic Catheter
21.6.10 Nov 06, 2009: Edwards Announces First Implant Of Edwards SAPIEN Valve In Japan
21.6.11 Nov 02, 2009: Edwards Lifesciences And DexCom Announces Receipt Of CE Mark For Glucose Monitoring System
21.6.12 Sep 08, 2009: Edwards Lifesciences Successfully Completes The Clincial Use Of Ascendra 2 Transapical Delivery System
21.6.13 Aug 31, 2009: Edwards Lifesciences Completes Patient Enrollment In PARTNER Trial For Edwards SAPIEN Transcatheter Heart Valve
21.6.14 Aug 17, 2009: Edwards Lifesciences Corporation To Complete PREVAIL EU Trial For Edwards SAPIEN XT Valve In The First Quarter Of 2015
21.6.15 Jun 30, 2009: Research Demonstrates Edwards Lifesciences' PORT ACCESS System Facilitates Improved Outcomes Compared To Sternotomy
21.6.16 May 20, 2009: Edwards Lifesciences Presents Positive Results From Largest Transcatheter Valve Implant Series At EuroPCR 2009
21.6.17 May 14, 2009: Edwards Lifesciences Announces Successful Completion Of First Human Implants With 18 French Transcatheter Valve System
21.6.18 May 08, 2009: Edwards Lifesciences' Carpentier-Edwards PERIMOUNT Magna Ease Aortic Valve Receives FDA Approval
21.6.19 Mar 17, 2009: Edwards Lifesciences Announces Patient Enrollment Completion In Non-Surgical Study Arm Of US Clinical Trial For Transcatheter Valve
21.6.20 Feb 15, 2009: Edwards Lifesciences Announces The European Approval For RetroFlex Transfemoral Delivery System
21.6.21 Jan 26, 2009: Edwards Lifesciences To Introduce Its Carpentier-Edwards Physio II Mitral Valve Repair Ring At STS
21.6.22 Oct 14, 2008: Survival Rates Rise In Studies Of Edwards Heart Valves
21.6.23 Oct 13, 2008: Edwards Lifesciences' New Transcatheter Heart Valve Data Demonstrate Positive Results
21.6.24 Sep 15, 2008: Edwards Lifesciences Presents New Transcatheter Heart Valve Data At EACTS
21.6.25 Sep 03, 2008: Edwards Wins FDA Approval For Mitral Heart Valve
21.6.26 May 12, 2008: Edwards Lifesciences Introduces New Transcatheter Valve Delivery System At EuroPCR 2008
21.6.27 Apr 18, 2008: Edwards Lifesciences Announces First Implants In US Study Of Minimally-Invasive Pulmonic Valve
21.6.28 Jan 29, 2008: Edwards Lifesciences Receives FDA Approval To Add Transapical Delivery System To US Clinical Trial Of Transcatheter Heart Valve
21.6.29 Jan 04, 2008: Edwards SAPIEN Transcatheter Heart Valve Training Program Launches In Europe
21.7 Other Significant Developments
21.7.1 Oct 21, 2009: Edwards Lifesciences Contributes $15 Million To Its Charitable Fund
21.7.2 Aug 13, 2009: Edwards Lifesciences To Receive About $11.5 Million From GOED
21.7.3 Mar 27, 2009: LeMaitre Terminates Distribution Agreement With Edwards Lifesciences For Its AlboGraft Vascular Graft
21.7.4 Jan 05, 2009: Edwards Lifesciences To Present At The 27th Annual JP Morgan Healthcare Conference
21.7.5 Dec 02, 2008: Edwards Lifesciences Spent $0.11 Million Lobbying In 3Q 2008
21.7.6 Nov 13, 2008: The Edwards Lifesciences Fund Awards More Than $1.8 Million To 81 Nonprofit Organizations
21.7.7 Nov 05, 2008: Edwards Lifesciences To Present At Credit Suisse Conference
21.7.8 Sep 16, 2008: Edwards Lifesciences To Present At UBS Conference
21.7.9 May 27, 2008: Edwards Lifesciences Spent $0.16 Million Lobbying In Q1 2008
22 Appendix
22.1 Research Methodology
22.2 Secondary Research
22.3 Primary Research
22.4 Models
22.5 Forecasts
22.6 Expert Panels
22.7 Consulting
22.8 Currency Conversion
22.9 Contact Us
22.10 Disclaimer

Abbott Laboratories
ATS Medical, Inc.
Becton, Dickinson and Company
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C.R. Bard, Inc.
Cordis Corporation
LiDCO Group Plc
Medtronic, Inc.
Philips Healthcare
PULSION Medical Systems AG
Sorin Group
St. Jude Medical, Inc.
Terumo Corporation
ZOLL Medical Corporation

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report